Feb
25

India Ink: Laliji, the Octogenarian from Bihar

Why do millions of people, from entire Indian villages to urbane middle managers to foreign tourists, brave the crowds at the Kumbh Mela? During this year’s 55-day pilgrimage, to Allahabad, Uttar Pradesh, an estimated 100 million Hindus and others are expected to take a holy dip in the Ganges River to wash away their sins. India Ink interviewed some of them.Laliji, 80, from Chhapra, Bihar, was one...
Read More..

Anne Hathaway's Oscar Dress Had You Talking

By Maggie Coughlan 02/25/2013 at 08:30 AM EST The Oscars may honor the best in film, but they'd be nothing without the fashion.When Anne Hathaway stepped on to the red carpet in a light pink backless Prada gown at Sunday's 85th Annual Academy Awards, she made quite the fashion statement. While the gown seemed simple from the front, at second...
Read More..

FDA approves new targeted breast cancer drug

WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a potent...
Read More..

Stock futures point to higher open, Barnes & Noble rallies

NEW YORK (Reuters) - U.S. stock index futures pointed to a higher open on Monday, suggesting the equity rally was intact despite concerns that the Federal Reserve could curtail its stimulus for the economy sooner than many expected. Stocks have been strong performers so far this year, with the S&P 500 jumping 6.2 percent in 2013 to hover around its highest levels since 2007. That...
Read More..
Feb
24

IHT Rendezvous: Opera for an Era When Money Is Tight

VIENNA—Not long ago it looked as if cuts in arts funding would sound the death knell of the Vienna Chamber Opera, known in German as the Kammeroper, an ensemble esteemed for its chamber-scale productions in an intimate, inviting setting. The Austrian federal government’s decision to eliminate entirely its support, which constituted half of the company’s governmental subsidies (the other half coming...
Read More..

You're Invited to PEOPLE.com's Oscars Party!

02/24/2013 at 08:40 AM EST From left: Bradley Cooper, Oscar, Jessica Chastain AFP/Getty; Wireimage; Splash News Online Oscars host Seth MacFarlane isn't the only one gearing up for Hollywood's biggest night – we are too! Be a part of the glamour and excitement Sunday at 6 p.m. ET when we...
Read More..

FDA approves new targeted breast cancer drug

WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a potent...
Read More..
Feb
23

India Ink: In Hyderabad, Anger and Frustration

Srinivas Mahesh, 28, was snacking outside his hostel near the Konark Theater in Dishknagar, his usual hangout in Hyderabad, when he heard a loud explosion Thursday evening. Not long after, he saw smoke filling up the air. Once he realized it was a bomb blast, instead of rushing back to his hostel he resolved to helping the injured.“I saw disfigured bodies for the first time in my life,” he said. He...
Read More..

Biggest Loser's Francelina Morillo: Jeff Nichols and I 'Have Something Special'

TV Watch The Biggest Loser By Patrick Gomez 02/23/2013 at 08:30 AM EST Francelina Morillo and Jeff Nichols Trae Patton/NBC (2) Francelina Morillo may have lost the chance to win the title of Biggest Loser, but she has found love."We have something special," Morillo...
Read More..

FDA approves new targeted breast cancer drug

WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a potent...
Read More..